{"id":"https://openalex.org/W2124408208","doi":"https://doi.org/10.1093/eurheartj/ehi132","title":"Soluble CD40 ligand in acute and chronic heart failure","display_name":"Soluble CD40 ligand in acute and chronic heart failure","publication_year":2005,"publication_date":"2005-02-16","ids":{"openalex":"https://openalex.org/W2124408208","doi":"https://doi.org/10.1093/eurheartj/ehi132","mag":"2124408208","pmid":"https://pubmed.ncbi.nlm.nih.gov/15716285"},"language":"en","primary_location":{"id":"doi:10.1093/eurheartj/ehi132","doi":"https://doi.org/10.1093/eurheartj/ehi132","is_oa":false,"landing_page_url":"https://doi.org/10.1093/eurheartj/ehi132","pdf_url":null,"source":{"id":"https://openalex.org/S181568219","display_name":"European Heart Journal","issn_l":"0195-668X","issn":["0195-668X","1522-9645"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Heart Journal","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039625009","display_name":"Thor Ueland","orcid":"https://orcid.org/0000-0001-5005-0784","observed_orcids":["https://orcid.org/0000-0001-5005-0784"]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Thor Ueland","raw_affiliation_strings":["Research Institute for Internal Medicine, Rikshospitalet University Hospital, N-0027 Oslo, Norway. thor.ueland@klinmed.uio.no"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Institute for Internal Medicine, Rikshospitalet University Hospital, N-0027 Oslo, Norway. thor.ueland@klinmed.uio.no","institution_ids":["https://openalex.org/I1281400175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008853144","display_name":"P\u00e5l Aukrust","orcid":"https://orcid.org/0000-0003-0919-836X","observed_orcids":["https://orcid.org/0000-0003-0919-836X","https://orcid.org/0000-0002-6509-6221"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P\u00e5l Aukrust","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111570158","display_name":"Arne Yndestad","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Arne Yndestad","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078394585","display_name":"Kari Otterdal","orcid":"https://orcid.org/0009-0007-4854-9931","observed_orcids":["https://orcid.org/0009-0007-4854-9931"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kari Otterdal","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110781179","display_name":"Stig Sophus Fr\u00f8land","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stig S. Fr\u00f8land","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110354360","display_name":"Kenneth Dickstein","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kenneth Dickstein","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025930905","display_name":"JOHN K. KJEKSHUS","orcid":"https://orcid.org/0000-0003-4306-1244","observed_orcids":["https://orcid.org/0000-0003-4306-1244"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John Kjekshus","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022181712","display_name":"Lars Lysgaard Gullestad","orcid":"https://orcid.org/0000-0002-5932-6641","observed_orcids":["https://orcid.org/0000-0002-5932-6641"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lars Gullestad","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5066572584","display_name":"Jan K. Dam\u00e5s","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jan K. Dam\u00e5s","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5240,"currency":"EUR","value_usd":5922},"apc_paid":null,"fwci":5.1901,"has_fulltext":false,"cited_by_count":85,"citation_normalized_percentile":{"value":0.95825899,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"26","issue":"11","first_page":"1101","last_page":"1107"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.6338000297546387,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.6338000297546387,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11962","display_name":"Cardiac Fibrosis and Remodeling","score":0.33719998598098755,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14165","display_name":"Inflammation biomarkers and pathways","score":0.0031999999191612005,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/soluble-cd40-ligand","display_name":"soluble CD40 ligand","score":0.9990000128746033},{"id":"https://openalex.org/keywords/heart-failure","display_name":"heart failure","score":0.9459999799728394},{"id":"https://openalex.org/keywords/acute-heart-failure","display_name":"acute heart failure","score":0.8240000009536743},{"id":"https://openalex.org/keywords/chronic-heart-failure","display_name":"chronic heart failure","score":0.984000027179718},{"id":"https://openalex.org/keywords/myocardial-infarction","display_name":"myocardial infarction","score":0.9309999942779541},{"id":"https://openalex.org/keywords/inflammation","display_name":"inflammation","score":0.8420000076293945},{"id":"https://openalex.org/keywords/pro-inflammatory-cytokines","display_name":"inflammatory cytokines","score":0.8389999866485596},{"id":"https://openalex.org/keywords/ace-inhibitors","display_name":"ACE inhibitors","score":0.7210000157356262},{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":0.9049999713897705},{"id":"https://openalex.org/keywords/captopril","display_name":"captopril","score":0.843999981880188},{"id":"https://openalex.org/keywords/losartan","display_name":"losartan","score":0.9919999837875366},{"id":"https://openalex.org/keywords/warfarin","display_name":"warfarin","score":0.9620000123977661},{"id":"https://openalex.org/keywords/neurohormonal-activation","display_name":"neurohormonal activation","score":0.7960000038146973},{"id":"https://openalex.org/keywords/left-ventricular-dysfunction","display_name":"left ventricular dysfunction","score":0.9950000047683716},{"id":"https://openalex.org/keywords/diabetes-mellitus","display_name":"diabetes mellitus","score":0.7739999890327454},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.7480000257492065},{"id":"https://openalex.org/keywords/myocarditis","display_name":"myocarditis","score":0.42899999022483826}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9363787174224854},{"id":"https://openalex.org/C39347974","wikidata":"https://www.wikidata.org/wiki/Q21135811","display_name":"CD40","level":4,"score":0.7000093460083008},{"id":"https://openalex.org/C2779479957","wikidata":"https://www.wikidata.org/wiki/Q421119","display_name":"Captopril","level":3,"score":0.6725215911865234},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.6611834168434143},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6434155106544495},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.5589362382888794},{"id":"https://openalex.org/C2908929049","wikidata":"https://www.wikidata.org/wiki/Q65963433","display_name":"Angiotensin II","level":3,"score":0.5421226620674133},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.534635066986084},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.5330544710159302},{"id":"https://openalex.org/C2780288358","wikidata":"https://www.wikidata.org/wiki/Q410074","display_name":"Losartan","level":4,"score":0.4536702632904053},{"id":"https://openalex.org/C2779611605","wikidata":"https://www.wikidata.org/wiki/Q288280","display_name":"ACE inhibitor","level":4,"score":0.4152246415615082},{"id":"https://openalex.org/C27016395","wikidata":"https://www.wikidata.org/wiki/Q128861","display_name":"Angiotensin-converting enzyme","level":3,"score":0.39961281418800354},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.352252721786499},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.12588360905647278},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.10972169041633606},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.0},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000208","descriptor_name":"Acute Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000806","descriptor_name":"Angiotensin-Converting Enzyme Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002216","descriptor_name":"Captopril","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002908","descriptor_name":"Chronic Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006333","descriptor_name":"Heart Failure","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D006333","descriptor_name":"Heart Failure","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009203","descriptor_name":"Myocardial Infarction","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019808","descriptor_name":"Losartan","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D023201","descriptor_name":"CD40 Ligand","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D047228","descriptor_name":"Angiotensin II Type 1 Receptor Blockers","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1093/eurheartj/ehi132","doi":"https://doi.org/10.1093/eurheartj/ehi132","is_oa":false,"landing_page_url":"https://doi.org/10.1093/eurheartj/ehi132","pdf_url":null,"source":{"id":"https://openalex.org/S181568219","display_name":"European Heart Journal","issn_l":"0195-668X","issn":["0195-668X","1522-9645"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Heart Journal","raw_type":"journal-article"},{"id":"pmid:15716285","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15716285","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European heart journal","raw_type":"Clinical Trial"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.512.307","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.512.307","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://eurheartj.oxfordjournals.org/content/26/11/1101.full.pdf","raw_type":"text"},{"id":"pmh:oai:open-archive.highwire.org:ehj:ehi132v1","doi":null,"is_oa":false,"landing_page_url":"http://eurheartj.oxfordjournals.org/cgi/content/short/ehi132v1","pdf_url":null,"source":{"id":"https://openalex.org/S4406923041","display_name":"HighWire Press Open Archive","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"TEXT"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W143537947","https://openalex.org/W1487706069","https://openalex.org/W1528551608","https://openalex.org/W1561516029","https://openalex.org/W1956481325","https://openalex.org/W1967128858","https://openalex.org/W1974159422","https://openalex.org/W1980087271","https://openalex.org/W1989138086","https://openalex.org/W2000844847","https://openalex.org/W2006968633","https://openalex.org/W2008674682","https://openalex.org/W2019951936","https://openalex.org/W2021011733","https://openalex.org/W2033819584","https://openalex.org/W2037683223","https://openalex.org/W2059396660","https://openalex.org/W2059404314","https://openalex.org/W2062079696","https://openalex.org/W2063562293","https://openalex.org/W2075479845","https://openalex.org/W2083884874","https://openalex.org/W2089884451","https://openalex.org/W2095844672","https://openalex.org/W2106410529","https://openalex.org/W2110640974","https://openalex.org/W2124421822","https://openalex.org/W2134202905","https://openalex.org/W2140396611","https://openalex.org/W2142039559","https://openalex.org/W2166206612","https://openalex.org/W2398120660"],"related_works":["https://openalex.org/W7100391858","https://openalex.org/W2384460982","https://openalex.org/W2949615143","https://openalex.org/W1995333942","https://openalex.org/W2388155213","https://openalex.org/W2391312687","https://openalex.org/W2132481488","https://openalex.org/W2076112754","https://openalex.org/W3012464915","https://openalex.org/W2033819584"],"abstract_inverted_index":{"AIMS:":[0],"Inflammatory":[1],"cytokines":[2],"may":[3,178,189],"play":[4],"a":[5,191],"pathogenic":[6,192],"role":[7,24,32,193],"in":[8,18,25,35,49,74,128,135,183,198],"heart":[9],"failure":[10],"(HF).":[11],"CD40-CD40":[12],"ligand":[13],"(CD40L)":[14],"interactions":[15,197],"are":[16],"important":[17],"atherogenesis":[19],"and":[20,68,73,156,173,180],"based":[21],"on":[22],"its":[23],"inflammation":[26],"we":[27],"sought":[28],"to":[29],"evaluate":[30],"the":[31,115,126,168,174],"of":[33,43,121,170],"CD40L":[34,46],"human":[36,199],"HF.":[37,79,185,200],"METHODS":[38],"AND":[39],"RESULTS:":[40],"Serum":[41],"levels":[42,111],"soluble":[44],"(s)":[45],"were":[47,105,112],"measured":[48],"236":[50],"patients":[51,76,85,104,136,141],"with":[52,59,77,86,95,118,142,151],"acute":[53,87],"HF":[54,88,144],"following":[55],"myocardial":[56],"infarction,":[57],"treated":[58],"either":[60],"angiotensin-converting":[61],"enzyme":[62],"(ACE)-inhibition":[63],"or":[64,99,123],"angiotensin":[65],"II":[66],"blockade":[67],"followed":[69,106],"for":[70,194],"2":[71],"years,":[72],"116":[75],"chronic":[78,143,184],"Our":[80,187],"main":[81],"findings":[82,188],"were:":[83],"(i)":[84],"had":[89,146],"increased":[90],"sCD40L":[91,110,129,182],"levels,":[92],"particularly":[93],"those":[94],"severe":[96],"HF,":[97],"diabetes,":[98],"hypertension;":[100],"(ii)":[101],"when":[102],"these":[103],"longitudinally,":[107],"persistently":[108],"raised":[109,147],"found":[113],"throughout":[114],"observation":[116],"period":[117],"no":[119],"effect":[120],"captopril":[122],"losartan;":[124],"(iii)":[125],"increase":[127],"during":[130],"follow-up":[131],"was":[132],"not":[133],"seen":[134],"receiving":[137],"warfarin":[138],"therapy;":[139],"(iv)":[140],"also":[145],"sCD40L,":[148],"significantly":[149],"correlated":[150],"clinical":[152],"severity,":[153],"neurohormonal":[154],"dysregulation,":[155],"left":[157],"ventricular":[158],"dysfunction;":[159],"(v)":[160],"studies":[161],"from":[162],"different":[163],"blood":[164],"compartments":[165],"suggest":[166,190],"that":[167],"vasculature":[169],"lower":[171],"extremities":[172],"failing":[175],"myocardium":[176],"itself":[177],"produce":[179],"secrete":[181],"CONCLUSION:":[186],"enhanced":[195],"CD40-CD40L":[196]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}